Clopiwa AP Capsule

Clopiwa AP Capsule is a combination of Aspirin/Acetylsalicylic acid and Clopidogrel belongs to the antiplatelet drug class, is a synergistic approach to prevent blood clot formation.

Aspirin acts by blocking the cyclooxygenase party, inhibiting thromboxane A2 production, a troublemaker that encourages platelet gathering.

Simultaneously, clopidogrel, a thienopyridine, disrupts platelet activation by inhibiting adenosine receptors. Together, they form a dynamic duo, ensuring smooth blood flow and preventing clotting.

Follow your doctor's guidance on the prescribed dose and duration. The medicine can be taken with or without food, but maintaining a consistent daily time is recommended for optimal results.

The combination of Aspirin and Clopidogrel increases the risk of bleeding. Monitor for signs of bleeding, such as easy bruising, prolonged bleeding, or unusual bleeding from the gums. This risk is higher in individuals with bleeding disorders or those taking other medications that increase bleeding risk. Inform healthcare providers about all medications, including over-the-counter drugs and supplements, to prevent potential interactions.

Common side effects may include diarrhea, nausea, constipation, flatulence, dyspepsia, nosebleeds, bruising, and gastrointestinal bleeding. Monitoring these side effects is essential, and any concerns should be reported promptly to your healthcare provider.

If you miss a dose, take it when you remember. If the next dose is close, skip the missed one, and continue with the regular schedule. Avoid taking two doses at once. Consult your doctor for guidance on managing missed doses effectively. Consistent adherence to prescribed doses is crucial for the effectiveness of antiplatelet therapy.